Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCorcept Therapeutics Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$0.15 | -$0.05 | -$0.11 |
| Q2 2026 | 3 | -$0.01 | $0.03 | $0.01 |
| Q3 2026 | 3 | $0.16 | $0.26 | $0.23 |
| Q4 2026 | 1 | $0.46 | $0.54 | $0.50 |
| Q1 2027 | 1 | $0.27 | $0.32 | $0.30 |
| Q2 2027 | 1 | $0.53 | $0.62 | $0.58 |
| Q3 2027 | 1 | $0.68 | $0.79 | $0.75 |
| Q4 2027 | 1 | $0.76 | $0.89 | $0.84 |
Corcept Therapeutics Inc Earnings Date And Information
Corcept Therapeutics Inc last posted its earnings results on Thursday, April 30th, 2026. The company reported $-0.3 earnings per share for the quarter, missing analysts' consensus estimates of $-0.142 by $0.158. The company had revenue of 164.90 M for the quarter and had revenue of 761.41 M for the year. Corcept Therapeutics Inc has generated $1 earnings per share over the last year ($0.82 diluted earnings per share) and currently has a price-to-earnings ratio of 124.44. Corcept Therapeutics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Corcept Therapeutics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/30/2026 | Q1 2026 | -$0.14 | -$0.30 | -0.16 | $185.27 M | $164.90 M |
| 02/24/2026 | Q4 2025 | $0.33 | $0.23 | -0.1 | $256.88 M | $202.13 M |
| 11/04/2025 | Q3 2025 | $0.18 | $0.19 | 0.01 | $223.16 M | $207.64 M |
| 07/31/2025 | Q2 2025 | $0.23 | $0.33 | 0.1 | $199.39 M | $194.43 M |
| 05/05/2025 | Q1 2025 | $0.17 | $0.19 | 0.02 | $177.93 M | $157.21 M |
| 02/26/2025 | Q4 2024 | $0.37 | $0.29 | -0.08 | $198.74 M | $181.89 M |
| 10/30/2024 | Q3 2024 | $0.28 | $0.45 | 0.17 | $171.97 M | $182.55 M |
| 07/29/2024 | Q2 2024 | $0.23 | $0.34 | 0.11 | $155.14 M | $163.80 M |
| 05/01/2024 | Q1 2024 | $0.22 | $0.27 | 0.05 | $141.19 M | $146.81 M |
| 02/15/2024 | Q4 2023 | $0.26 | $0.30 | 0.04 | N/A | $135.41 M |
| 11/01/2023 | Q3 2023 | $0.22 | $0.31 | 0.09 | N/A | $123.60 M |
| 08/02/2023 | Q2 2023 | $0.15 | $0.27 | 0.12 | N/A | $117.72 M |
| 05/03/2023 | Q1 2023 | $0.19 | $0.15 | -0.04 | N/A | $105.65 M |
| 02/28/2023 | Q4 2022 | $0.23 | $0.15 | -0.08 | N/A | $103.06 M |
| 11/03/2022 | Q3 2022 | $0.23 | $0.30 | 0.07 | N/A | $101.73 M |
| 08/03/2022 | Q2 2022 | N/A | $0.24 | N/A | N/A | $103.39 M |
| 05/05/2022 | Q1 2022 | $0.24 | $0.20 | -0.04 | N/A | $93.69 M |
| 02/15/2022 | Q4 2021 | $0.22 | $0.28 | 0.06 | N/A | $98.82 M |
| 11/03/2021 | Q3 2021 | $0.20 | $0.26 | 0.06 | N/A | $96.13 M |
| 07/29/2021 | Q2 2021 | $0.16 | $0.23 | 0.07 | N/A | $91.59 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Corcept Therapeutics Inc Earnings: FAQ's
The conference call for Corcept Therapeutics Inc's latest earnings report can be listened to online.
The conference call transcript for Corcept Therapeutics Inc's latest earnings report can be read online.
Corcept Therapeutics Inc (:CORT) has a recorded annual revenue of $761.41 M.
Corcept Therapeutics Inc (:CORT) has a recorded net income of $99.65 M.Corcept Therapeutics Inc has generated $0.95 earnings per share over the last four quarters.
Corcept Therapeutics Inc (:CORT) has a price-to-earnings ratio of 124.44 and price/earnings-to-growth ratio is -1.93.